BioPharma
13 May, 2026 | Wednesday | News
Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene therapies, ProBio Inc. and Curocell have achieved a signi...
Lab
07 May, 2026 | Thursday | News
Ribbon's launches Synthetic MiroSynth Cell-Free DNA product manufactured without bacterial cloning steps. The company has also launched the MiroMine kit, allowing customers to create synthetic DNA cons...
BioTech
12 May, 2026 | Tuesday | News
2.3 trillion yen in oncology revenue to be delivered by 2030 through the launch of 20 new indications across five medicines Identifying breakthrough generating technologies and strengthening of standalone ...
Contract Services
06 May, 2026 | Wednesday | News
Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines VectorBuilder, a global leader in gene delivery technologies and CDMO services, ann...
Consumer Health
11 May, 2026 | Monday | News
As hearing care evolves beyond conventional amplification models, personalisation is emerging as a critical factor in improving patient outcomes and long term device adoption. In this exclusiv...
Medtech
05 May, 2026 | Tuesday | News
Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic Procedures Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced ...
Cell & Gene
13 May, 2026 | Wednesday | News
Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products (ATMPs), and Dark Horse Consulting Group ("DHCG" or "the Group"), a lead...
White Paper
24 April, 2026 | Friday | Analysis
Product Spot Light
07 May, 2026 | Thursday | News
Premium Article
14 April, 2026 | Tuesday | Opinion
Bio Invest
13 May, 2026 | Wednesday | News
Biopharma APAC Infomercial